Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Symbol
AUTL
Shares outstanding
264,805,464 shares
Disclosed Ownership
2,568,613 shares
Ownership
0.97%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 08:08:18 UTC
Date of event
30 Sep 2025

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 0.97% ownership in Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share (AUTL) on 30 Sep 2025."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G/A for Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share (AUTL).
  • Disclosed ownership: 0.97%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 08:08.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 0.97% 2,568,613 0 2,568,613 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 0.97% 2,568,613 0 2,568,613 /s/ David Kroin David Kroin, Director
David Kroin 0.97% 2,568,613 0 2,568,613 /s/ David Kroin David Kroin